Trial Profile
A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2013
Price :
$35
*
At a glance
- Drugs Romidepsin (Primary)
- Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 23 Aug 2005 New trial record.